Perceptive is a technology-enabled service provider supporting preclinical and clinical trials through imaging and Interactive Response Technology (IRT) and Randomized Trial Supply Management (RTSM). Founded in 2024, the company operates across the US, Europe, the UK, and Asia, serving pharmaceutical, biotech, and clinical research organisations. Its offerings span three main product lines: Perceptive Discovery for preclinical and translational imaging services including radiochemistry and in vivo imaging; Perceptive eClinical for cloud-based randomisation, trial supply management, and electronic clinical outcome assessments; and Perceptive Imaging, an independent imaging core laboratory for clinical trials worldwide.
The company's combined specialised experience in clinical trial imaging and IRT/RTSM exceeds 50 years. Perceptive has supported nearly 12,000 clinical trials and contributed to more than 800 regulatory approvals. Its technical domains include clinical trial imaging, preclinical imaging, IRT/RTSM, radiochemistry, in vivo imaging, cloud-based randomisation, trial supply management, and electronic clinical outcome assessments.
Perceptive delivers its services on a 24/7 basis, reflecting the round-the-clock demands of global clinical research operations. The company's global footprint and breadth of capabilities position it as a full-service partner for organisations requiring imaging, randomisation, and supply management solutions throughout the drug development lifecycle.
